Option chain shows key data for CIE Automotive's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CIE Automotive.

CIE Automotive (OTC:CUOTF) Stock, Option Chain

CIE Automotive SA is a supplier of components and subassemblies for the automotive market. Cie Automotive produces components for engines, gearboxes, transmissions, chassis, interior and exterior trims, and roof systems. The company's clients include Renault, Magna, Chrysler, Daimler, Schaeffler, Ford, Nexteer, Volkswagen, and Faurecia. Next to its core automotive business, Cie Automotive operates a process improvement service through a subsidiary. The majority of revenue and operating profits are generated in Cie Automotive's core segment automotive components. Geographically, Europe and NAFTA are the largest sources of operating profits for the company.

CIE AUTOMOTIVE SA ORD by Cie Automotive SA

CIE Automotive SA

Health Care

General

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

Kiora Gets Approval To Begin KLARITY, A Phase 2 Clinical Trial To Investigate KIO-104 In Patients With Retinal Macular Edem

BP PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) shares are trading lower after <a href="https://www.bp.com/content/dam/bp/business-sites/en/global/corporate/pdfs/investors/bp-fourth-quarter-2024-results.pdf" target="_blank" rel="noreferrer noopener">the </a>company reported fourth-quarter results.
Sales and other operating revenues came in at&nbsp;$45.752 billion, missing the consensus of&nbsp;$47.511 billion.
Hydrocarbon production was 850 mboe/d (-5.4% Y/Y), with underlying production declining&nbsp;2.7% Y/Y mainly due to base decline in Egypt.
The Renewables pipeline stood at 60.6GW (bp net), including a 38.7GW bp net share from Lightsource bp&#8217;s (LSbp&#8217;s) pipeline in the quarter.&nbsp;
Adjusted EBITDA declined to&nbsp;$8.41 billion from&nbsp;$10.57 billion a year ago.&nbsp;Underlying RC profit per American Depositary Share (ADS) came in at&nbsp;$0.44,<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener"> missing the consensus of&nbsp;$0.47.&nbsp;</a>
Operating cash flow was&nbsp;$7.43 billion, compared to&nbsp;$9.38 billion in the prior-year quarter.&nbsp;
Capital expenditure was&nbsp;$3.73 billion versus&nbsp;$4.71 billion a year ago.&nbsp;Net debt rose to&nbsp;$23.0 billion from&nbsp;$20.9 billion a year ago.
Chief executive officer Murray Auchincloss said, &#8220;We have been reshaping our portfolio &#8211; sanctioning new major projects, and focusing our low-carbon investment &#8211; and we have made strong progress in reducing costs. Building on the actions taken in the last 12 months, we now plan to fundamentally reset our strategy and drive further improvements in performance, all in service of growing cash flow and returns.&#8221;
Kate Thomson, Chief Financial Officer, stated, &#8220;During the year, we introduced our target to deliver at least $2 billion of savings(a) by the end of 2026 relative to 2023 and are making strong progress, achieving $0.8 billion of structural cost reduction. We raised the dividend per ordinary share by 10% and delivered $7 billion of share buybacks.&#8221;
Related: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43608991/bp-set-to-report-q4-earnings-as-elliot-management-builds-stake" rel="noreferrer noopener">BP Set To Report Q4 Earnings As Elliot Management Builds Stake: Declining Margins, Revenues In The Spotlight</a>
Dividend: BP disclosed an interim dividend of 8.000 cents per ordinary share, payable on March 28, 2025. Holders of ADSs are expected to receive&nbsp;$0.48 per ADS.
Repurchase: The company completed previously announced&nbsp;$1.75 billion in share buybacks during the quarter.
Furthermore, BP plans to conduct a&nbsp;$1.75 billion&nbsp;share buyback before its&nbsp;first-quarter&nbsp;earnings release.
Elliott Management, a U.S.-based activist hedge fund managing approximately $70 billion in assets, reportedly acquired a stake in BP. The fund advocates for substantial changes at the British oil <a target="_blank" href="https://www.benzinga.com/news/large-cap/25/02/43591241/whats-going-on-with-oil-giant-bp-stock-today" rel="noreferrer noopener">company to boost its performance</a>.
First-Quarter FY25&nbsp;Outlook: BP anticipates upstream production to be lower than the&nbsp;fourth quarter&nbsp;of 2024.
In its customer business, BP projects seasonally lower volumes sequentially, with fuel margins likely remaining sensitive to supply cost fluctuations.
In the products segment, BP expects refining margins to stay low in the&nbsp;first quarter and expects a lower level of refinery turnaround activity compared to the fourth quarter of 2024.
FY25&nbsp;Guidance: BP&nbsp;expects reported upstream production to be lower and underlying upstream production to be&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">slightly lower than the prior year</a>.&nbsp;
It anticipates divestments and other proceeds to be around $3 billion&nbsp;for the year, with weighted towards the second half.
BP anticipates approximately $3 billion in divestment and other proceeds in 2025, primarily in the second half.
With $22 billion realized since the second quarter of 2020, the company remains on track to achieve its $25 billion target for the 2020-2025 period.
The company sees Gulf of America settlement payments for the year to be about $1.2 billion&nbsp;pre-tax, including&nbsp;$1.1 billion&nbsp;pre-tax to be paid during the&nbsp;second quarter.
Yesterday, BP inked a contract with Oil and Natural Gas Corporation Limited (ONGC), as per which bp will serve as the Technical Services Provider (<a target="_blank" href="https://www.bp.com/en/global/corporate/news-and-insights/press-releases/ongc-and-bp-sign-contract-to-enhance-production-from-mumbai-high.html" rel="noreferrer noopener">TSP</a>) for the Mumbai High field, India&#8217;s largest and most prolific offshore oil field.
Investors can gain exposure to the stock via&nbsp;Texas Capital Texas Oil Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OILT#NYSE">OILT</a>) and Abacus FCF Real Assets Leaders ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ABLD#BATS">ABLD</a>).
Price Action: BP shares are trading lower by 0.67% at $34.19 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43614105/activist-investor-elliott-builds-25-billion-stake-in-phillips-66-pressures-for-midstream-spinoff-report" target="_blank" rel="noreferrer noopener">Activist Investor Elliott Builds $2.5 Billion Stake In Phillips 66, Pressures For Midstream Spinoff: Report</a></li>
</ul>
Photo: Jon Lyall via Shutterstock.

Earnings

Equities

Large Cap

News

Guidance

ABLD

OILT

BP Q4 Results: Lower Revenue, Rising Debt, CEO Pledges Fundamental Strategy Shift And More

HC Wainwright &amp; Co. analyst Scott Buck reiterates Mitek Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITK#NASDAQ">MITK</a>) with a Buy and maintains $13 price target.

Price Target

Reiteration

Analyst Ratings

MITK

HC Wainwright & Co. Reiterates Buy on Mitek Systems, Maintains $13 Price Target

Travel

Travelers Companies Sees $1.7 billion Pre-tax Losses Relating To The January 2025 California Wildfires

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fisglobal.com%2F&amp;esheet=54203542&amp;newsitemid=20250211419904&amp;lan=en-US&amp;anchor=FIS&amp;index=1&amp;md5=d6b7c456ff60084466ef02824ba6d642">FIS</a><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fisglobal.com%2F&amp;esheet=54203542&amp;newsitemid=20250211419904&amp;lan=en-US&amp;anchor=%26%23174%3B&amp;index=2&amp;md5=12565643be68b6daf87725dd4438c846">&#xAE;</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>), a global leader in financial technology, today announced a new strategic partnership with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.affirm.com%2F&amp;esheet=54203542&amp;newsitemid=20250211419904&amp;lan=en-US&amp;anchor=Affirm&amp;index=3&amp;md5=6577b18686c487227bae496b2e437929">Affirm</a>, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), the payment network that can empower consumers and help merchants drive growth, making Affirm its integrated pay-over-time provider for debit issuers. Together, FIS and Affirm will deliver a new program that enables FIS' vast network of banking clients to integrate Affirm's industry-leading solution into their existing debit program via their digital banking and mobile app platforms, allowing their customers to easily manage their finances in a single place.
This collaboration is well-timed, as banks are searching for new and innovative options to meet consumer needs and demands for flexible purchasing solutions. This program offers a substantial opportunity for financial institutions to provide a sought-after pay-over-time solution to the millions of U.S. consumers who have a debit card. By integrating Affirm's offering into banking products, FIS continues to unlock growth opportunities for clients across the money lifecycle, help meet the demands of the growing market and strategically position financial institutions to capitalize on the offering's potential by fostering customer loyalty and accelerating growth.

AFRM

FIS Partners With Affirm to Bring Pay-Over-Time Option to Debit Card Users

On Tuesday, Inspira Technologies OXY B.H.N. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IINN#NASDAQ">IINN</a>) announced <a target="_blank" href="https://www.benzinga.com/profile/inspira-technologies" rel="noreferrer noopener">positive initial results</a> from its previously reported collaboration with Ennocure MedTech to develop a novel bio-electronic treatment for preventing bloodstream infections.
In ex-vivo porcine skin model testing, the bio-electronic patch demonstrated a 95% reduction in bacterial presence within 4 hours, with continued effectiveness observed over 24 hours.
The technology, which uses physical electric stimulation rather than chemical agents, showed promising results in preventing pathogen growth on treated surfaces.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43596316/mondaycom-q4-earnings-beats-estimates-with-32-revenue-growth-ceo-highlights-ai-as-a-game-changer-for-2025" rel="noreferrer noopener">Monday.com Beats Q4 Earnings Estimates, Boasts 32% Revenue Growth: CEO Calls AI A Game-Changer</a>
Inspira Technologies chief Dagi Ben-Noon noted an estimated 250,000 bloodstream infections related to intravenous lines occurring worldwide yearly. The approach could offer significant advantages in critical care settings.
Bio-electronic technology can address several key challenges associated with traditional IV dressings, including prevention of bacterial growth through physical rather than chemical means, potential for extended wear time, reduced frequency of dressing changes, applicability to both skin surface and cannula areas, and real-time monitoring capabilities.
Price Action: IINN stock is down 3.35% at $0.8206 premarket at last check on Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43593383/tower-semiconductor-q4-earnings-beats-eps-estimates-expands-ai-chip-production-for-2025-growth" target="_blank" rel="noreferrer noopener">Tower Semiconductor Q4 Earnings: Beats EPS Estimates, Expands AI Chip Production For 2025 Growth, Stock Falls As Outlook Disappoints The Street</a></li>
</ul>

Market-Moving Exclusives

Exclusives

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

EXCLUSIVE: Inspira and Ennocure's Bio-Electronic Tech Uses Electric Stimulation to Help Prevent IV-Related Infections

Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 11th:
OMV Aktiengesellschaft OMVKY: This energy and chemicals company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
<div class="chart_embed">
<h3>OMV AG Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/OMVKY/price-consensus-chart?icid=chart-OMVKY-price-consensus-chart"><img alt="OMV AG Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f0/1739262717.png" style="height:264px; width:527px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/OMVKY/price-consensus-chart?icid=chart-OMVKY-price-consensus-chart">OMV AG price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/OMVKY?icid=chart-OMVKY-price-consensus-chart">OMV AG Quote</a>
</div>
OMV has a price-to-earnings ratio (P/E) of 5.96, compared with 7.30 for the industry. The company possesses a <a href="https://www.zacks.com/style-scores-education/">Value Score</a>&nbsp; of A.
<div class="chart_embed">
<h3>OMV AG PE Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/OMVKY/fundamental/pe-ratio-ttm?icid=chart-OMVKY-fundamental/pe-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/c9/1739262943.png&quot; title=&quot;&quot; width=&quot;493&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/OMVKY/fundamental/pe-ratio-ttm?icid=chart-OMVKY-fundamental/pe-ratio-ttm">OMV AG pe-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/OMVKY?icid=chart-OMVKY-fundamental/pe-ratio-ttm">OMV AG Quote</a>
</div>
Pacira BioSciences, Inc. PCRX: This non-opioid pain management and regenerative health solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 21% over the last 60 days.
<div class="chart_embed">
<h3>Pacira BioSciences, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PCRX/price-consensus-chart?icid=chart-PCRX-price-consensus-chart"><img alt="Pacira BioSciences, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/18/1739262729.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PCRX/price-consensus-chart?icid=chart-PCRX-price-consensus-chart">Pacira BioSciences, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PCRX?icid=chart-PCRX-price-consensus-chart">Pacira BioSciences, Inc. Quote</a>
</div>
Pacira has a price-to-earnings ratio (P/E) of 7.69, compared with 24.45 for the S&amp;P 500. The company possesses a Value Score of A.
<div class="chart_embed">
<h3>Pacira BioSciences, Inc. PE Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/PCRX/fundamental/pe-ratio-ttm?icid=chart-PCRX-fundamental/pe-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/35/1739262962.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/PCRX/fundamental/pe-ratio-ttm?icid=chart-PCRX-fundamental/pe-ratio-ttm">Pacira BioSciences, Inc. pe-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/PCRX?icid=chart-PCRX-fundamental/pe-ratio-ttm">Pacira BioSciences, Inc. Quote</a>
</div>
EZCORP, Inc. EZPW: This pawn services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
<div class="chart_embed">
<h3>EZCORP, Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart"><img alt="EZCORP, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/f4/1739262742.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/EZPW/price-consensus-chart?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/EZPW?icid=chart-EZPW-price-consensus-chart">EZCORP, Inc. Quote</a>
</div>
Ezcorp has a price-to-earnings ratio (P/E) of 10.33, compared with 15.30 for the industry. The company possesses a Value Score of A.
<div class="chart_embed">
<h3>EZCORP, Inc. PE Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/EZPW/fundamental/pe-ratio-ttm?icid=chart-EZPW-fundamental/pe-ratio-ttm">TTM</a>)&quot; height=&quot;251&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/b8/1739262981.png&quot; title=&quot;&quot; width=&quot;532&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/EZPW/fundamental/pe-ratio-ttm?icid=chart-EZPW-fundamental/pe-ratio-ttm">EZCORP, Inc. pe-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/EZPW?icid=chart-EZPW-fundamental/pe-ratio-ttm">EZCORP, Inc. Quote</a>
</div>
&nbsp;
See <a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link">the full list of top ranked stocks here.</a>
&nbsp;
Learn more about the <a href="https://www.zacks.com/education/stock-scorecard/value-trading">Value score and how it is calculated here.</a>
&nbsp;
<h2>Only $1 to See All Zacks&#39; Buys and Sells</h2>
We&#39;re not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like&nbsp;Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/6328?adid=SYND_BENZ_ZU_ZU_ZACKS1RANKADDITIONS_268_02112025_2413286&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286" style="font-weight:bold">See Stocks Now &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ZACKS1RANKADDITIONS_268_2413286&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=EZPW&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_268_2413286_EZPW&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">EZCORP, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PCRX&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_268_2413286_PCRX&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">Pacira BioSciences, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/pcrx#NASDAQ">PCRX</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=OMVKY&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_268_2413286_OMVKY&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">OMV AG (OMVKY): Free Stock Analysis Report</a>
<a href="https://www.zacks.com/commentary/2413286/best-value-stocks-to-buy-for-february-11th?cid=CS-BENZ-FT-zacks_1_rank_additions|value_additions-2413286">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Small Cap

Markets

EZPW

PCRX

Best Value Stocks To Buy For February 11th

EXCLUSIVE: Inspira Technologies Tells Benzinga 'Initial ex-vivo testing demonstrates significant bacterial reduction potential for innovative IV dressing technology aimed at preventing bloodstream infections'

EXCLUSIVE: Inspira Technologies Tells Benzinga Co. Reports Pre-Clinical Results From Bio-Electric Anti-Bacterial Technology Collaboration With Ennocure

UBS analyst Lloyd Walmsley upgrades Compass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) from Neutral to Buy and raises the price target from $7 to $11.

Upgrades

COMP

UBS Upgrades Compass to Buy, Raises Price Target to $11

Wedbush analyst Nick Setyan maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Outperform and raises the price target from $320 to $330.

Wedbush Maintains Outperform on McDonald's, Raises Price Target to $330

The Company projects accelerated organic growth in 2025 supported by secular tailwinds, continued innovation and double-digit aftermarket growth.
<ul>
<li>Mid-single digit organic&#x2A; growth; Reported sales of $22.5 – $23.0 billion
<ul>
<li>Commercial Refrigeration divestiture represents a ~$750 million sales headwind versus prior year</li>
</ul>
</li>
<li>Adjusted operating margin&#x2A; of 16.5% – 17.0%, up ~100 basis points compared to 2024</li>
<li>Adjusted EPS&#x2A; of $2.95 – $3.05, up mid to high-teens</li>
<li>Free cash flow&#x2A; of $2.4 – $2.6 billion</li>
<li>Expect to repurchase ~$3 billion in shares</li>
</ul>

CARR

Carrier Global Sees FY25 Sales OF $22.5B – $23.0B (vs. Cons. $23.0B), Adj. EPS Of $2.95 – $3.05 (vs. Cons. $2.99)

VIAV

VIAVI Launches Edge Grandmaster Clock Offering Up To 25G Precision Time Protocol (PTP) And Multi-Orbit SecureTime

2025 Guidance
The Company estimates net income attributable to Curbline for 2025 to be from $0.48 to $0.56 per diluted share and Operating FFO to be from $0.97 to $1.01 per diluted share. The Company does not include a projection of gains or losses on asset sales, transaction costs or debt extinguishment costs in guidance.
Reconciliation of Net Income Attributable to Curbline to FFO and Operating FFO estimates:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
FY 2025E
Per Share — Diluted
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net income attributable to Curbline</td>
<td colspan="1" rowspan="1">$0.48 — $0.56</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Depreciation and amortization of real estate</td>
<td colspan="1" rowspan="1">0.49 — 0.45</td>
</tr>
<tr>
<td colspan="1" rowspan="1">FFO (NAREIT) and Operating FFO</td>
<td colspan="1" rowspan="1">$0.97 — $1.01</td>
</tr>
</tbody>
</table>
</figure>

CURB

Curbline 2025 Guidance: Expects Net Income Per Share Of $0.48–$0.56, And Operating FFO Of $0.97–$1.01 Per Share (Vs. $0.96 Est.)

U.S. stock futures fell on Tuesday after ending higher on Monday amid a revenue miss from McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) and weak ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) earnings. All four benchmark indices were trading lower.
President Donald Trump imposed the promised 25% tariff on steel and aluminum imports on Monday, including from Canada and Mexico, targeting metal products to protect U.S. industries and counteract efforts by countries like Russia and China to bypass existing duties.
The 10-year Treasury yield stood at 4.52%, while the two-year yield was at 4.28%. According <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">to</a> the CME Group's FedWatch tool, there is a 93.5% chance that the Federal Reserve will keep interest rates unchanged for the March meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.52%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.39%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.25%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.53%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) both experienced negative premarket trading on Tuesday. SPY fell 0.35% to $602.76, and QQQ declined 0.44% to $526.93, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Chipmakers led a Nasdaq <a href="https://www.benzinga.com/news/earnings/25/02/43615981/nasdaq-gains-1-as-nvidia-broadcom-rise-investor-sentiment-improves-fear-greed-index-moves-to-neutral-zone">surge</a> of nearly 1% on Monday, with Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), and Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) all posting significant gains.
This tech sector strength, along with energy and utilities gains, propelled the S&amp;P 500 and the Dow Jones. Despite last week&#8217;s losses driven by inflation and tariff concerns, Monday saw investors shrug off those worries.
Financials and utilities were the only S&amp;P 500 sectors to close lower. Inflation expectations remained steady at 3% for January.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.98%</td>
<td>19,714.27</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.67%</td>
<td>6,066.44</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.38%</td>
<td>44,470.41</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.36%</td>
<td>2,287.94</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Wharton finance professor Jeremy Siegel, in a podcast, forecasted that the stock market's response would be entirely contingent on the duration of the tariffs. &#8220;As long as these tariffs are in effect and are not lowered, it&#8217;s very hard to see the stock market going up," stated Siegel.
&#8220;Trump's tariffs are now higher on the mind of investors than most of the economic data and will likely be the most important mover of stocks until the last set of data before the March meeting,&#8221; he added in his weekly commentary note.
The chief market strategist at Carson Research, Ryan Detrick highlighted a data point comparing the S&amp;P 500&#8217;s December lows to the next year&#8217;s first quarter low.
According to this data, if the S&amp;P 500 index falls below its previous year&#8217;s December low in the first quarter of a new year, it is likely that the full-year return could be negative.
The index fell by 0.2% on average for the full year when the first quarter&#8217;s lowest level has fallen below December&#8217;s lowest level.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">One big worry I have is the S&amp;P 500 in Q1 violated it&#39;s December closing low. The returns for the full yr are much worse when this happens vs doesn&#39;t happen. Years like '73, '74, tech bubble, '08, and '22 all made this infamous list. Now 2025. <a href="https://t.co/nEtUjpGapw">pic.twitter.com/nEtUjpGapw</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1889067316417073271?ref_src=twsrc%5Etfw">February 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, on the economic front, former Treasury Secretary Larry Summers warned the proposed tariffs would lead to "fewer American jobs, more American inflation, and probably a bigger trade deficit," questioning potential national security benefits from tariffing allies.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I&#39;m sorry that Trump&#39;s threatened steel and aluminum tariffs have now been implemented. This will mean fewer American jobs, more American inflation and because of damage to us exports probably a bigger trade deficit. I do not see any national security gain from tariffing Canada.
&mdash; Lawrence H. Summers (@LHSummers) <a href="https://twitter.com/LHSummers/status/1889114367645344099?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul>
<li>On Tuesday, January&#8217;s NFIB optimism index data will be released at 6:00 a.m., ET.</li>
</ul>
<ul>
<li>Cleveland Fed President Beth Hammack will speak at 8:50 a.m., ET.</li>
</ul>
<ul>
<li>Fed Chairman Jerome Powell&#8217;s testimony to Congress begins at 10:00 a.m., ET.</li>
</ul>
<ul>
<li>San Francisco Fed President Mary C Daly will speak at 10:20 a.m., and New York Fed President John C Williams and Fed Governor Michelle Bowman will speak at 3:30 p.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) was up 0.01% in premarket on Tuesday ahead of its earnings, which will be released before the opening bell. Analysts expect it to report quarterly earnings of 52 cents per share on revenue of $10.68 billion.</li>
</ul>
<ul>
<li>Marriott International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) fell 0.16% as Wall Street expects it to report quarterly earnings of $2.38 per share on revenue of $6.38 billion before the opening bell.</li>
</ul>
<ul>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) gained 3.42% ahead of its earnings, which will be released before the opening bell. Analysts expect it to report quarterly earnings of 43 cents per share on revenue of $2.73 billion.</li>
</ul>
<ul>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) rose 0.05% as Wall Street expects it to report quarterly earnings of $1.70 per share on revenue of $7.14 billion after the closing bell.</li>
</ul>
<ul>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) was down 25.63% after it reported better-than-expected earnings for its fourth quarter but issued weak guidance for the first quarter.</li>
</ul>
<ul>
<li>Fluence Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) was down 35.42% after it reported first-quarter revenue of $186.8 million, representing a 49% decrease year-over-year. Net loss increased to $57.0 million from $25.6 million year-over-year.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 1.27% to hover around $73.24 per barrel.
The gold spot index was down by 0.15% to $2,903.52 per ounce. The Dollar Index was down 0.01% at 108.309 level.
Asian markets were mixed on Monday. Australia's ASX 200, South Korea's Kospi, and Japan's Nikkei 225 index advanced. Whereas, China's CSI 300, and Hong Kong's Hang Seng index fell. European markets were mostly higher in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43616409/warren-buffetts-berkshire-hathaway-loads-up-on-sirius-xm-amid-price-target-cuts-company-pays-dividend-but-better-off-in-t-bills-says-expert">Warren Buffett&#8217;s Berkshire Hathaway Loads Up On Sirius XM Amid Price Target Cuts: Company Pays Dividend &#8216;But Better Off In T-Bills,&#8217; Says Expert</a></li>
</ul>
Photo courtesy: Shutterstock

Government

Economics

Pre-Market Outlook

AVGO

FLNC

GILD

HLIT

NVDA

SHOP

US Stock To Likely Open Lower Amid Tariff Tensions: Expert Hints Sans Lower Tariffs It's Hard To See The 'Market Going Up'

<h4>Key Takeaways:</h4>
<ul>
<li>Huawei reported its second-highest annual revenue in 2024, driven by strong sales for its smartphone and smart vehicle businesses</li>
<li>The company&rsquo;s HarmonyOS will be key to its overseas smartphone expansion, filling a void after Huawei was forced to abandon Google&rsquo;s Android under U.S. sanctions</li>
</ul>
&nbsp;&nbsp;
By Xia Fei
Once written off as a casualty of U.S. sanctions, telecoms giant&nbsp;Huawei Technologies&nbsp;is showing that notices of its death may have been premature. From regaining its crown in China&rsquo;s smartphone market to taking a lead in the country&rsquo;s smart car solutions, the company is defying tough odds using its own innovation and mostly homegrown Chinese technology.
The fruits of those efforts were reflected in some newly disclosed financials for 2024 given by Chairman Liang Hua at a meeting last week hosted by the Guangdong provincial government. At the meeting,&nbsp;<a href="https://www.scmp.com/tech/big-tech/article/3297540/tech-war-huaweis-2024-revenue-surges-22-cent-despite-us-sanctions">Liang said</a>&nbsp;Shenzhen-based Huawei generated 860 billion yuan ($118 billion) in revenue last year, up 22% year-on-year, and its second-highest total behind only the 891 billion yuan it earned in 2020.
The growth was driven mostly by a resurgence in its smartphone sales and rapid growth in its smart vehicle solutions business, Liang said, even as he described 2024 as a year &ldquo;full of challenges&rdquo;. He didn&rsquo;t provide any details beyond the headline figure, and as a private company Huawei has always been selective about the financial information it publicly discloses.
But in an annual letter to staff last month, Yu Chengdong, chief executive of Huawei&rsquo;s consumer business group, said the company&rsquo;s terminal business, which includes its smartphones, &ldquo;returned to the fast track of growth in 2024 after five consecutive years of sanctions.&rdquo;
The rebound comes as Huawei, whose businesses range from smartphones to telecoms equipment and smart car solutions, has become a poster child for U.S. efforts to deter China&rsquo;s technological rise.
The assault began in 2019, when the first administration of U.S. president Donald Trump banned U.S. government agencies from using products made by firms including Huawei, citing a national security risk. The U.S. Commerce Department later barred Huawei from obtaining American technology without government permission. Such restrictions were quickly expanded to curb Huawei&rsquo;s access to semiconductor chips as well as Google&rsquo;s Android operating system.
Escalating U.S. sanctions led Huawei to sell its Honor-brand smartphone business in November 2020 to ensure the budget brand&rsquo;s survival without the burden of all the restrictions placed on Huawei. The company&rsquo;s annual revenue tumbled to 636 billion yuan in 2021 from 891 billion in 2020 as a result, and the figure improved only modestly in 2022 and 2023 to 642 billion yuan and 704 billion yuan, respectively.
<h4>Regaining the crown</h4>
Huawei&rsquo;s smartphone business was its crown jewel before the sanctions, winning the company praise both at home and abroad for its products that targeted Apple at the high end of the market. That business took the biggest hit after Huawei lost access to the high-performance chips needed for such phones, and also to the Android operating system under U.S. sanctions. But it has made a rapid comeback in the past year after finding various substitutes.
Huawei&rsquo;s smartphones regained the top spot in China&rsquo;s smartphone market last year with 18.1% share, the first time it returned to the top spot since the U.S. sanctions began, according to Counterpoint. Its launch of two new models, including the Mate 70 series, featuring AI capabilities and its self-developed HarmonyOS NEXT operating system, was pivotal to its growth.
Huawei also surpassed South Korea&rsquo;s Samsung as the world&rsquo;s best-selling foldable smartphone brand in the first quarter of 2024 with 35% of the global market versus Samsung&rsquo;s 23%, according to Counterpoint. And in the first three quarters of last year, Huawei unseated Apple in the global wrist-worn wearables market, with nearly 17% share, according to IDC.
Those achievements were made possible as Huawei turned to local chipmaker SMIC to produce its proprietary high-end Kirin chipsets, after former partner TSMC was pressured by the U.S. to sever its relationship with the Chinese company.
Huawei&rsquo;s younger smart car solutions business was another bright spot for the company last year. Sales under its Harmony Intelligent Mobility Alliance collaboration with several automakers surpassed 430,000 units last year, said Yu in his letter to employees. In the first half of last year, the smart car unit posted 10.4 billion yuan in revenue and a 2.2 billion yuan profit, reversing massive losses of 7.58 billion yuan in 2022 and 5.59 billion yuan in 2023.
Despite being shunned in the U.S. and many Western markets, Huawei has pivoted to selling its telecoms equipment, the company&rsquo;s other major business, in developing countries, especially in Latin America.
The company remained a global leader in the telecoms equipment market, with 36.8% share in the second quarter of 2024, up 3.8 percentage points from a year earlier, according to Omdia, a market research firm. At the same time, Huawei and ZTE, another Chinese telecoms equipment maker blacklisted by the U.S, passed a major milestone by collectively controlling more than half of the global telecoms equipment market for the first time during the quarter. In contrast, European giants Ericsson and Nokia saw their share drop to 23% and 17.7%, respectively.
<h4>Rise of HarmonyOS</h4>
Another milestone for Huawei last year was the sale of more than 1 billion devices installed with its HarmonyOS operating system, up 25% year-on-year, as the operating system challenges Google&rsquo;s Android and Apple&rsquo;s iOS duopoly. Harmony passed iOS as the second-largest mobile operating system in China in the first quarter of 2024, Counterpoint data showed.
But doubts are emerging on whether HarmonyOS NEXT can retain its momentum. A stripped-down version of the popular WeChat app created for Harmony is getting lukewarm reviews from users in early testing. And a revival in domestic Chinese smartphone sales may be short-lived, as an initial boost in demand from a government-backed consumer goods trade-in program fades.
Meanwhile, last year&rsquo;s stunning revenue growth doesn&rsquo;t mean Huawei is out of the woods yet. Despite the strong top-line growth, Huawei&rsquo;s profit still declined by 14% to 62.9 billion yuan in the first nine months of 2024, possibly reflecting its hefty investment in R&amp;D.
Huawei&rsquo;s next ambition is to recover ground its smartphones lost overseas after it was banned from working with Google in Android. To convince users outside China to abandon their iOS- or Android-based phones, however, could take a lot more effort, especially at a time when the global market is sluggish as users change gadgets less frequently.
Geopolitical tensions and security concerns in the West could also hinder Huawei&rsquo;s ability to rebuild its global presence. The U.S may intensify efforts to further restrict Chinese access to more services and technologies under a second Trump administration as trade tensions grow. And while Huawei has shown it can bypass Washington&rsquo;s technological restrictions, winning over consumers abroad with its unfamiliar HarmonyOS may take longer.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Huawei Rings Up Improbable Comeback As Revenue Soars

NNVC

NanoViricides Says Its Antiviral Drug NV-387 Can Fight Bird Flu Pandemic

JP Morgan analyst Pinjalim Bora maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Overweight and raises the price target from $350 to $400.

MNDY

JP Morgan Maintains Overweight on Monday.Com, Raises Price Target to $400

Mizuho analyst Maheep Mandloi upgrades First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) from Neutral to Outperform and raises the price target from $218 to $259.

FSLR

Mizuho Upgrades First Solar to Outperform, Raises Price Target to $259

Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.17 by 35.29 percent. This is a 35.29 percent increase over earnings of $0.17 per share from the same period last year. The company reported $34.924 million in sales this quarter. This is a 37.12 percent increase over sales of $25.470 million the same period last year.

Comments

CIE Automotive

CIE Automotive (CUOTF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga